门诊癌症手术后电子患者报告症状
这项回顾性队列研究分析了2016年9月至2022年6月在纪念斯隆凯特琳癌症中心Josie Robertson手术中心接受五种常见门诊癌症手术的12433例患者,通过Recovery Tracker电子患者报告结局平台在术后10天评估症状。共发放110936份问卷,应答率87%,症状负担总体中等,术后第1至3天最重,疼痛和疲劳最常见,严重症状少见。
要点
- 门诊癌症手术后症状负担总体中等,最高严重程度出现在术后第1至3天。
- 疲劳见于6120/10814例(57%),但很少严重;极重度疼痛和疲劳分别见于324/10814例(3%)和106/10814例(1%)。
- 严重或极严重疼痛比例最高为肾切除术92/332例(28%),其次为乳房切除加重建817/3322例(25%)和前列腺切除术744/3543例(21%)。
核心结论
- 通过该分析定义详细的术后症状负担,为外科肿瘤患者远程症状监测项目的进一步实施和维护提供有价值的数据。
- 这些数据可加强患者教育、设定预期,并支持研究以基于患者报告体验实现临床照护的迭代改进。
研究设计与样本
- 回顾性队列研究,纳入2016年9月至2022年6月在纪念斯隆凯特琳癌症中心Josie Robertson手术中心接受前列腺切除术、肾切除术、乳房切除术、子宫切除术或甲状腺切除术中一种的患者。
- 患者术后10天完成Recovery Tracker电子患者报告结局平台症状评估,数据分析时间为2022年9月至2023年5月。
- 共12433例患者被分配110936份问卷;7874例(63%)为女性,手术时中位(IQR)年龄为57(47-65)岁。
主要发现
- 问卷应答率为87%(10814例患者至少回复10份每日问卷中的1份);在至少提交1份问卷的患者中,中位(IQR)提交问卷数为7(4-8)份,每次评估中位(IQR)耗时1.7(1.2-2.5)分钟。
- 该人群症状负担中等,最高严重程度出现在术后第1至3天;疼痛初期为中度并稳步改善;疲劳见于6120/10814例(57%),但很少严重。
- 极重度疼痛和疲劳分别见于324/10814例(3%)和106/10814例(1%);最大疼痛严重程度(严重或极严重)最高为肾切除术92/332例(28%),其次为乳房切除加重建817/3322例(25%)和前列腺切除术744/3543例(21%)。
- 恶心(偶尔、频繁或几乎持续)常见且多日发生,见于1485/9300例(16%),但呕吐较少见139/10812例(1%);体温高于38°C见于740/10812例(7%);严重或极严重气短见于125/10813例(1%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Complex cancer procedures are now performed in the ambulatory surgery setting. Remote symptom monitoring (RSM) with electronic patient-reported outcomes (ePROs) can identify patients at risk for acute hospital encounters. Defining normal recovery is needed to set patient expectations and optimize clinical team responses to manage evolving problems in real time. OBJECTIVE: To describe the patterns of postoperative recovery among patients undergoing ambulatory cancer surgery with RSM using an ePRO platform-the Recovery Tracker. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study, patients who underwent 1 of 5 of the most common procedures (prostatectomy, nephrectomy, mastectomy, hysterectomy, or thyroidectomy) at the Josie Robertson Surgery Center at Memorial Sloan Kettering Cancer Center from September 2016 to June 2022. Patients completed the Recovery Tracker, a brief ePRO platform assessing symptoms for 10 days after surgery. Data were analyzed from September 2022 to May 2023. MAIN OUTCOMES AND MEASURES: Symptom severity and interference were estimated by postoperative day and procedure. RESULTS: A total of 12 433 patients were assigned 110 936 surveys. Of these patients, 7874 (63%) were female, and the median (IQR) age at surgery was 57 (47-65) years. The survey response rate was 87% (10 814 patients responding to at least 1 of 10 daily surveys). Among patients who submitted at least 1 survey, the median (IQR) number of surveys submitted was 7 (4-8), and each assessment took a median (IQR) of 1.7 (1.2-2.5) minutes to complete. Symptom burden was modest in this population, with the highest severity on postoperative days 1 to 3. Pain was moderate initially and steadily improved. Fatigue was reported by 6120 patients (57%) but was rarely severe. Maximum pain and fatigue responses (very severe) were reported by 324 of 10 814 patients (3%) and 106 of 10 814 patients (1%), respectively. The maximum pain severity (severe or very severe) was highest after nephrectomy (92 of 332 [28%]), followed by mastectomy with reconstruction (817 of 3322 [25%]) and prostatectomy (744 of 3543 [21%]). Nausea (occasionally, frequently, or almost constantly) was common and experienced on multiple days by 1485 of 9300 patients (16%), but vomiting was less common (139 of 10 812 [1%]). Temperature higher than 38 °C was reported by 740 of 10 812 (7%). Severe or very severe shortness of breath was reported by 125 of 10 813 (1%). CONCLUSIONS AND RELEVANCE: Defining detailed postoperative symptom burden through this analysis provides valuable data to inform further implementation and maintenance of RSM programs in surgical oncology patients. These data can enhance patient education, set expectations, and support research to allow iterative improvement of clinical care based on the patient-reported experience after discharge.
引用
- Cracchiolo JR, Tin AL, Assel M, et al. Electronic Patient-Reported Symptoms After Ambulatory Cancer Surgery. JAMA Surg. 2024. PMID: 38477892. doi:10.1001/jamasurg.2024.0133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。